Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heat stability of a recombinant DNA hepatitis B vaccine.
Van Damme P, Cramm M, Safary A, Vandepapelière P, Meheus A. Van Damme P, et al. Among authors: vandepapeliere p. Vaccine. 1992;10(6):366-7. doi: 10.1016/0264-410x(92)90064-q. Vaccine. 1992. PMID: 1534639 Clinical Trial.
Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule.
Papaevangelou G, Karvelis E, Alexiou D, Kiossoglou K, Roumeliotou A, Safary A, Collard F, Vandepapeliere P. Papaevangelou G, et al. Among authors: vandepapeliere p. Vaccine. 1995 Feb;13(2):175-8. doi: 10.1016/0264-410x(95)93132-s. Vaccine. 1995. PMID: 7625112 Clinical Trial.
Randomized, single-blind comparison of the immunogenicity and reactogenicity of 20 micrograms and 10 micrograms doses of hepatitis B vaccine in adolescents.
Poovorawan Y, Pongpunlert W, Theamboonlers A, Vimolgej L, Chumdermpadetsuk S, Vandepapeliere P, Safary A. Poovorawan Y, et al. Among authors: vandepapeliere p. Southeast Asian J Trop Med Public Health. 1993 Jun;24(2):255-9. Southeast Asian J Trop Med Public Health. 1993. PMID: 8266226 Clinical Trial.
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G, Van Belle P, Vandepapeliere P, Horsmans Y, Janssens M, Carletti I, Garçon N, Wettendorff M, Van Mechelen M. Leroux-Roels G, et al. Among authors: vandepapeliere p. Vaccine. 2015 Feb 18;33(8):1084-91. doi: 10.1016/j.vaccine.2014.10.078. Epub 2014 Nov 7. Vaccine. 2015. PMID: 25444781 Free article.
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G. Vandepapelière P, et al. Vaccine. 2008 Mar 4;26(10):1375-86. doi: 10.1016/j.vaccine.2007.12.038. Epub 2008 Jan 14. Vaccine. 2008. PMID: 18272264 Clinical Trial.
33 results